samedan logo
 
 
spacer
home > pmps > autumn 2021 > cleaning up pharma’s act
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Cleaning Up Pharma’s Act



The dangers of dust in any workplace environment are well documented. From a business point of view, a build-up of dust can negatively impact productivity and potentially harm the quality of a product through contamination. While from a health perspective, regularly inhaling dust can cause respiratory illnesses and diseases.

In recent years, there has been a strong focus in the UK to improve the health and safety of workers, and it has been great to see a rise in the uptake of providing safe and clean work environments. The coronavirus pandemic brought with it new challenges of keeping workspaces safe, and, while all industries have had to endure an extremely difficult and unprecedented period, one positive is that we will be better prepared for such events in the future. Indeed, the pandemic has put a stronger need for stringent infection control in every sector. The pharma sector is renowned for having strict hygiene and cleanliness requirements, and COVID-19 has only heightened the need to maintain such a high level of health and safety in the industry, especially with the production of consumable synthetic and organic substances.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
James Miller, Director of Dustcontrol UK, has a wealth of experience in helping businesses control and prevent the spread of dust in the manufacturing, engineering, food processing, construction, and demolition industries, through providing dust extraction solutions and centralised vacuum systems to fit client requirements.

Print this page
Send to a friend
Privacy statement
News and Press Releases

LivaNova to Present Scientific Data on VNS Therapy for Difficult-to-Treat Depression at 4th International Brain Stimulation Conference

LivaNova PLC, a market-leading medical technology and innovation company, today announced its participation in the 4th International Brain Stimulation Conference, taking place December 6 - 9 in Charleston, S.C.
More info >>

White Papers

PROTEIN:PROTEIN INTERACTION ANALYSIS

IBA GmbH

Groth et al., 2007 and Jasencakova et al., 2010 Protein:protein-interactions (PPI) govern almost all important processes in living organisms. Thus, their rapid and accurate determination and investigation is a major challenge in life sciences. The extremely efficient and fast One-STrEP (Twin-Strep) system is suitable for the isolation of functional protein complexes and subsequent mass spectrometry analysis leads to the identification of protein complex components (Junttila et al., 2005) as it is shown in the following studies.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement